AU2001289506A1 - Pharmaceutical composition of dihydroartemisinin for treating malaria - Google Patents

Pharmaceutical composition of dihydroartemisinin for treating malaria

Info

Publication number
AU2001289506A1
AU2001289506A1 AU2001289506A AU8950601A AU2001289506A1 AU 2001289506 A1 AU2001289506 A1 AU 2001289506A1 AU 2001289506 A AU2001289506 A AU 2001289506A AU 8950601 A AU8950601 A AU 8950601A AU 2001289506 A1 AU2001289506 A1 AU 2001289506A1
Authority
AU
Australia
Prior art keywords
dihydroartemisinin
pharmaceutical composition
treating malaria
malaria
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001289506A
Inventor
Guoqiao Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHONGQING KINCARE MEDICINAL DEVELOPMENT Co Ltd
Original Assignee
CHONGQING KINCARE MEDICINAL DE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4582950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001289506(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by CHONGQING KINCARE MEDICINAL DE filed Critical CHONGQING KINCARE MEDICINAL DE
Publication of AU2001289506A1 publication Critical patent/AU2001289506A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2001289506A 2000-08-23 2001-05-31 Pharmaceutical composition of dihydroartemisinin for treating malaria Abandoned AU2001289506A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN00113134 2000-08-23
CNB001131346A CN1135974C (en) 2000-08-23 2000-08-23 Antimalarial compound dihydroartemisinin
PCT/CN2001/000884 WO2002026226A1 (en) 2000-08-23 2001-05-31 Pharmaceutical composition of dihydroartemisinin for treating malaria

Publications (1)

Publication Number Publication Date
AU2001289506A1 true AU2001289506A1 (en) 2002-04-08

Family

ID=4582950

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001289506A Abandoned AU2001289506A1 (en) 2000-08-23 2001-05-31 Pharmaceutical composition of dihydroartemisinin for treating malaria

Country Status (3)

Country Link
CN (1) CN1135974C (en)
AU (1) AU2001289506A1 (en)
WO (1) WO2002026226A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7842719B2 (en) 2002-10-31 2010-11-30 Kemin Foods, L.C. Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virus
CN1255106C (en) 2003-09-26 2006-05-10 李国桥 Complex artemisia apiacea extract
CN1833644B (en) * 2005-03-18 2010-07-21 中国人民解放军第三军医大学 Abrotine, its derivative dihydro-abrotine, artemether, arteether and arte sunate in use of pharmacy
AP2525A (en) * 2006-05-17 2012-12-05 Ranbaxy Lab Ltd Antimarial therapy using a combination of synthetic artemisinin derivative and bisquinoline derivative
CN107929240A (en) * 2017-12-13 2018-04-20 桂林南药股份有限公司 Piperaquine phosphate oral liquid and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219865A (en) * 1987-05-08 1993-06-15 Hoechst Aktiengesellschaft Pharmaceutical combination for the prophylaxis and therapy of malaria
CN1081035C (en) * 1997-11-18 2002-03-20 广州市健桥医药科技发展有限公司 Antimalarial compound naphtholquine
CN1092048C (en) * 1998-06-02 2002-10-09 广州市健桥医药科技发展有限公司 Compound piperaquine tablet

Also Published As

Publication number Publication date
CN1305810A (en) 2001-08-01
CN1135974C (en) 2004-01-28
WO2002026226A1 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
AU2002313236A1 (en) Medicinal compositions
AU2001233081A1 (en) Composition for treatment of stress
AU2001266338A1 (en) Pharmaceutical compositions for angiogenic therapy
AU2002302147A1 (en) Pharmaceutical composition
AU2002258221A1 (en) Medicinal composition
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2000272858A1 (en) Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
AU2001230898A1 (en) Formulations and methods for administration of pharmacologically or biologicallyactive compounds
AU2002351388A1 (en) Methods and compositions for controlled release of drugs
AU2001289506A1 (en) Pharmaceutical composition of dihydroartemisinin for treating malaria
AU2002252981A1 (en) Pharmaceutical compositions containing beta-mimetic agents and having few side-effects
AU2001295979A1 (en) Medicinal compositions, dose and method for treating malaria
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2002337713A1 (en) Pharmaceutical compositions and methods for treating cancer
AU4698900A (en) Pharmaceutical compositions for treating malaria
AU2002354460A1 (en) Medicinal composition
AU2002246658A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2002331279A1 (en) Pharmaceutical composition for treating hypercholesterolaemia
AU1748001A (en) Pharmaceutical composition for treatment of diarrhea
AUPR520701A0 (en) Herbal composition for the treatment of drug addiction
AU2002315287A1 (en) Pharmaceutical composition comprising clavulanic acid
AUPR529701A0 (en) Pharmaceutical composition
AUPQ916700A0 (en) A method of preparing a pharmaceutical composition
AU2001264324A1 (en) Method of stabilizing medicinal compositions containing pravastatin